OrbiMed’s Stryker SYK Stock Holding History

OrbiMed’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.1M	Sell	159,100 -23,400	-13%	-$7.37M	0.93%	35
2026 Q1	$60M	Sell	182,500 -142,500	-44%	-$51.2M	1.19%	24
2025 Q4	$114M	Sell	325,000 -34,200	-10%	-$12.5M	2.33%	13
2025 Q3	$133M	Hold	359,200	–	–	3.12%	7
2025 Q2	$142M	Hold	359,200	–	–	3.55%	8
2025 Q1	$134M	Buy	359,200 +14,800	+4%	+$5.63M	3.19%	7
2024 Q4	$124M	Hold	344,400	–	–	2.55%	8
2024 Q3	$124M	Buy	344,400 +75,400	+28%	+$26M	2.26%	10
2024 Q2	$91.5M	Hold	269,000	–	–	1.81%	13
2024 Q1	$96.3M	Hold	269,000	–	–	1.76%	14
2023 Q4	$80.6M	Hold	269,000	–	–	1.61%	19
2023 Q3	$73.5M	Sell	269,000 -2,400	-0.9%	-$688K	1.56%	21
2023 Q2	$82.8M	Sell	271,400 -96,200	-26%	-$27.8M	1.5%	23
2023 Q1	$105M	Sell	367,600 -113,400	-24%	-$30.1M	2.06%	13
2022 Q4	$118M	Buy	481,000 +57,900	+14%	+$13.1M	2.25%	12
2022 Q3	$85.7M	Sell	423,100 -18,000	-4%	-$3.79M	1.59%	22
2022 Q2	$87.7M	Sell	441,100 -16,000	-4%	-$3.76M	1.59%	24
2022 Q1	$122M	Sell	457,100 -8,200	-2%	-$2.12M	1.98%	17
2021 Q4	$124M	Buy	465,300 +127,900	+38%	+$33.6M	1.6%	22
2021 Q3	$89M	Hold	337,400	–	–	0.98%	28
2021 Q2	$87.6M	Hold	337,400	–	–	0.89%	36
2021 Q1	$82.2M	Buy	337,400 +102,400	+44%	+$24.6M	0.77%	40
2020 Q4	$57.6M	Hold	235,000	–	–	0.5%	57
2020 Q3	$49M	Buy	+235,000	New	+$45.7M	0.62%	51
2020 Q2	–	Sell	-371,100	Closed	-$61.8M	–	156
2020 Q1	$61.8M	Buy	+371,100	New	+$72.5M	1.04%	33
2019 Q3	–	Sell	-54,000	Closed	-$11.1M	–	137
2019 Q2	$11.1M	Hold	54,000	–	–	0.17%	89
2019 Q1	$10.7M	Sell	54,000 -76,200	-59%	-$13.7M	0.17%	88
2018 Q4	$20.4M	Hold	130,200	–	–	0.38%	68
2018 Q3	$23.1M	Sell	130,200 -13,200	-9%	-$2.25M	0.28%	80
2018 Q2	$24.2M	Sell	143,400 -92,900	-39%	-$15.6M	0.29%	80
2018 Q1	$38M	Sell	236,300 -49,700	-17%	-$8.01M	0.47%	59
2017 Q4	$44.3M	Sell	286,000 -135,000	-32%	-$20.6M	0.56%	53
2017 Q3	$59.8M	Buy	421,000 +104,700	+33%	+$15M	0.57%	51
2017 Q2	$43.9M	Hold	316,300	–	–	0.46%	59
2017 Q1	$41.6M	Hold	316,300	–	–	0.47%	56
2016 Q4	$37.9M	Buy	316,300 +104,300	+49%	+$12M	0.48%	54
2016 Q3	$24.7M	Hold	212,000	–	–	0.28%	70
2016 Q2	$25.4M	Hold	212,000	–	–	0.27%	69
2016 Q1	$22.7M	Buy	212,000 +26,000	+14%	+$2.56M	0.24%	64
2015 Q4	$17.3M	Hold	186,000	–	–	0.16%	73
2015 Q3	$17.5M	Hold	186,000	–	–	0.18%	77
2015 Q2	$17.8M	Sell	186,000 -927,000	-83%	-$87.8M	0.15%	88
2015 Q1	$103M	Buy	1,113,000 +81,400	+8%	+$7.58M	0.88%	35
2014 Q4	$97.3M	Buy	1,031,600 +29,000	+3%	+$2.57M	0.93%	34
2014 Q3	$81M	Buy	1,002,600 +8,000	+0.8%	+$658K	0.85%	35
2014 Q2	$83.9M	Buy	994,600 +367,900	+59%	+$30M	0.98%	36
2014 Q1	$51.1M	Sell	626,700 -90,000	-13%	-$7.16M	0.63%	43
2013 Q4	$53.9M	Buy	716,700 +650,700	+986%	+$47.5M	0.79%	41
2013 Q3	$4.46M	Sell	66,000 -48,800	-43%	-$3.37M	0.08%	103
2013 Q2	$7.42M	Buy	+114,800	New	+$7.62M	0.16%	88

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed's SYK Position: Q2 2026 in Review

OrbiMed reduced its Stryker (SYK) stake by 13% in Q2 2026, selling an estimated $7.37M and leaving 159,100 shares worth $50.1M. The position accounts for 0.93% of the portfolio, ranked #35.

OrbiMed first reported a position in SYK in Q2 2013 and has held it in 50 quarters since. The position peaked at $142M in Q2 2025. 2,257 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

OrbiMed held 159,100 shares of Stryker worth $50.1M as of Q2 2026.
OrbiMed sold 23,400 Stryker shares in Q2 2026, an estimated $7.37M.
Stryker made up 0.93% of OrbiMed's portfolio in Q2 2026, its #35 holding.
OrbiMed first reported a position in Stryker in Q2 2013 and has held it in 50 quarters since.
OrbiMed's Stryker position peaked at $142M in Q2 2025.
2,257 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.